Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development and commercialization of the product. Medical devices and diagnostic instruments/equipment companies require various regulatory as well as testing services to implement product lifecycle. CROs are specifically designed to perform these services in order to reduce the in-house cost and time of the companies.
Zoetis and Cargill, Incorporated – Notable Market Players in Medical devices and diagnostics contract research organization Market
The medical devices and diagnostics contract research organization market majorly consists of the players such PAREXEL International Corporation, ICON PLC, WUXI APPTEC, Charles River Laboratories, Laboratory Corporation of America Holdings, North American Science Associates, Inc., Qserve Group B.V., IQVIA, Proxima Clinical Research, Inc., and Activa CRO among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.
Below is the list of the growth strategies done by the players operating in the medical devices and diagnostics contract research organization market:
| Year | News |
| March, 2021 | NAMSA acquired Minneapolis-based American Preclinical Services (APS), a full-service preclinical CRO. This purchase follows NAMSA’s acquisition of New York-based Syntactx, a leading clinical research services CRO, in January 2021. With the addition of APS’s portfolio of services, NAMSA will further enhance its already robust preclinical solutions by providing Sponsors with a broader range of laboratory models and analysis tools, including innovative surgical instrumentation and several state-of-the-art catheterization labs, imaging capabilities, and surgical suites. |
| January, 2020 | Qserve Group, the leading global medical device and in vitro diagnostics consultancy acquired a QA/RA/Clinical consulting group, Quasys Consult SA, with its office in Liège, Belgium. The addition of Quasys Consult is strategic for the Qserve Group, to have the ability to provide its services in French and expand its presence further into Europe. |
| September, 2019 | IQVIA Healthcare acquired genae that is a data-driven service provider with a focus on MedTech devices and technologies. genae, now IQVIA MedTech is handling the regulatory strategy, the study document creation compliant to the medical device regulations, the site selection, the submission to the Medical Device Unit of the FAGG/AFMPS, and the overall set-up and execution of the clinical trial. |
